Akili, Inc.
(NASDAQ CM: AKLI)
Rigrodsky Law, P.A. is investigating Akili, Inc. (“Akili”) regarding possible breaches of fiduciary duties and other violations of law related to Akili’s agreement to be acquired by Virtual Therapeutics. Under the terms of the agreement, Akili shareholders will receive $0.4340 per share in cash.